News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MARTIN JOHN C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Converted 914,333 shares
@ $0
Converted 756,971 shares
@ $0
Converted 205,260 shares
@ $16.15, valued at
$3.3M
Bought 75,800 shares
@ $19, valued at
$1.4M
Converted 866,667 options to buy
@ $0
Converted 717,509 preferred shares
@ $0
Converted convertible notes
@ $16.15, valued at
$0 |
|
| 10/08/2020 |
3
| MARTIN JOHN C (Director) has filed a Form 3 on Kronos Bio, Inc. |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
3
| MARTIN JOHN C (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Gifted 140,000 shares
@ $0
Sold 35,842 shares
@ $70.9048, valued at
$2.5M
Sold 13,958 shares
@ $71.9498, valued at
$1M
Sold 200 shares
@ $72.665, valued at
$14.5k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 11/05/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 8,000 shares
@ $68.6063, valued at
$548.9k
Sold 28,421 shares
@ $69.5308, valued at
$2M
Sold 13,579 shares
@ $70.1548, valued at
$952.6k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 47,376 shares
@ $74.1144, valued at
$3.5M
Sold 2,624 shares
@ $74.9962, valued at
$196.8k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 08/03/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 50,000 shares
@ $77.853, valued at
$3.9M
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 07/05/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 49,700 shares
@ $70.8023, valued at
$3.5M
Sold 300 shares
@ $71.36, valued at
$21.4k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 06/05/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 50,000 shares
@ $68.1299, valued at
$3.4M
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 05/11/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 9,496 options to buy
@ $65.69, valued at
$623.8k
Granted 2,283 restricted stock units
@ $0 |
|
| 05/03/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 50,000 shares
@ $72.1932, valued at
$3.6M
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 04/04/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 26,258 shares
@ $72.5099, valued at
$1.9M
Sold 13,080 shares
@ $73.3861, valued at
$959.9k
Sold 9,962 shares
@ $74.3291, valued at
$740.5k
Sold 700 shares
@ $74.9771, valued at
$52.5k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 03/13/2018 |
4
| MARTIN JOHN C (Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 1,309 options to buy
@ $80.72, valued at
$105.7k
Granted 310 restricted stock units
@ $0 |
|
| 03/05/2018 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 16,902 shares
@ $77.8401, valued at
$1.3M
Sold 26,575 shares
@ $78.9539, valued at
$2.1M
Sold 6,523 shares
@ $79.4913, valued at
$518.5k
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 02/23/2018 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 340 shares
@ $62.3475, valued at
$21.2k
Granted 21,380 shares
@ $0
Granted 18,630 shares
@ $0
Paid exercise price by delivering 19,354 shares
@ $80.69, valued at
$1.6M
|
|
| 02/05/2018 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 19,277 shares
@ $83.348, valued at
$1.6M
Sold 30,723 shares
@ $83.6873, valued at
$2.6M
Exercised 50,000 options to buy
@ $23.6, valued at
$1.2M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2017 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 60,732 shares
@ $75.1061, valued at
$4.6M
Sold 101 shares
@ $75.5701, valued at
$7.6k
Sold 12,500 shares
@ $74.3527, valued at
$929.4k
Exercised 73,333 options to buy
@ $21.575, valued at
$1.6M
|
|
| 11/03/2017 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 65,856 shares
@ $75.079, valued at
$4.9M
Sold 7,477 shares
@ $75.6045, valued at
$565.3k
Exercised 73,333 options to buy
@ $21.575, valued at
$1.6M
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| MARTIN JOHN C (Executive Chairman) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 315 shares
@ $59.33, valued at
$18.7k
Granted 11,924 shares
@ $0
Granted 8,572 shares
@ $0
Paid exercise price by delivering 25,271 shares
@ $70.31, valued at
$1.8M
Granted 123,210 options to buy
@ $70.31, valued at
$8.7M
|
|
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|